Abbott Covid Testing Kit Packages

The Utah Department of Health is conducting a sole source procurement (Solicitation NH22-34) to acquire specific COVID-19 testing kits from Abbott, targeting three distinct products: BinaxNOW COVID Antigen At-Home, ID NOW COVID-19 molecular assay, and BinaxNOW COVID Antigen. The procurement was publicly noticed on October 28, 2021, with proposal submissions due by November 4, 2021, at 12:00 PM MDT. The solicitation encompasses commodity codes for laboratory and scientific equipment (41100), drugs and pharmaceutical products (51000), and immunomodulating drugs including vaccines and antigens (51200). Potential vendors are provided an opportunity to challenge the sole source determination by submitting documentation proving they can provide comparable or equivalent products. The procurement contact is Nick Hughes (nhughes@utah.gov), and the process will be conducted using US Dollar currency, with potential for additional legislative appropriations to be added to the awarded contract.

The solicitation does not explicitly outline specific set-aside designations or restrictions for disadvantaged enterprises. The procurement appears to be open to qualified vendors who can demonstrate the ability to provide equivalent testing kit products. While no incumbent vendors are specifically named, the sole source nature suggests Abbott is the preferred vendor for these specific COVID-19 testing products. The notice indicates an intent to award a contract, though specific budget ranges or award values are not explicitly detailed in the provided documentation. The procurement allows for potential challenges to the sole source determination, creating an opportunity for other vendors to demonstrate their capability to meet the state's testing kit requirements. Additional legislative funding may supplement the contract, indicating potential flexibility in the total contract value.